Skip to main content
Top
Published in: Clinical & Experimental Metastasis 3/2008

01-05-2008 | Research Paper

Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells

Authors: Chiara Marconi, Francesca Bianchini, Antonella Mannini, Gabriele Mugnai, Salvatore Ruggieri, Lido Calorini

Published in: Clinical & Experimental Metastasis | Issue 3/2008

Login to get access

Abstract

The aim of this study was to investigate whether tumor cells as well as tumor-associated macrophages (TAMs) contribute to the generation of protease activities essential to tumor cell invasiveness, such as matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9), and the urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR). We found that the enhanced invasiveness through Matrigel-coated filters of B16 murine melanoma cells stimulated with IFNγ was associated with an higher expression of uPAR and MMP-9 in these cells. Moreover, treatment with anti-MMP-9 or anti-uPAR monoclonal antibodies abrogated the increase of invasiveness in IFNγ-stimulated melanoma cells, suggesting a cooperation of uPA system and MMP-9 in cytokine-stimulated invasiveness. Invasiveness through Matrigel was also enhanced in B16 melanoma cells exposed to a medium conditioned by TAMs, represented in our experimental model by thioglycollate-elicited macrophages co-cultivated with melanoma cells. Macrophages isolated from these co-cultures were found to express higher levels of uPAR and MMP-9 compared to macrophage cultures alone, and the pro-invasive activity of the co-culture-conditioned medium was abrogated by anti-MMP-9 monoclonal antibodies, but not anti-uPAR monoclonal antibodies. Furthermore, the enhanced uPAR and MMP-9 expression in macrophages co-cultivated with tumor cells seems a rather specific phenomenon, generated through a cell-to-cell contact mechanism. On the whole, our data point to a cooperation between tumor cells and macrophages elicited by tumor cells themselves in generating key enzymes essential in the promotion of tumor invasiveness, such as uPAR and MMP-9.
Literature
1.
go back to reference Andreasen PA, Kjoller L, Christensen L et al (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1–22PubMedCrossRef Andreasen PA, Kjoller L, Christensen L et al (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1–22PubMedCrossRef
2.
go back to reference Mignatti P, Rifkin DB (2000) Nonenzimatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Adv Cancer Res 78:103–157PubMedCrossRef Mignatti P, Rifkin DB (2000) Nonenzimatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Adv Cancer Res 78:103–157PubMedCrossRef
3.
go back to reference Del Rosso M, Fibbi G, Pucci M et al (2002) Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 193:193–207CrossRef Del Rosso M, Fibbi G, Pucci M et al (2002) Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 193:193–207CrossRef
4.
go back to reference Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMedCrossRef Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMedCrossRef
5.
go back to reference Sidenius N, Blasi F (2003) The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22:205–222PubMedCrossRef Sidenius N, Blasi F (2003) The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22:205–222PubMedCrossRef
6.
go back to reference De Vries TJ, Quax PH, Denijn M et al (1994) Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:70–81PubMed De Vries TJ, Quax PH, Denijn M et al (1994) Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:70–81PubMed
7.
go back to reference Hofmann UB, Westphal JR, Van Muijen GN et al (2000) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337–344PubMedCrossRef Hofmann UB, Westphal JR, Van Muijen GN et al (2000) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337–344PubMedCrossRef
8.
go back to reference Hofmann UB, Westphal JR, Waas ET et al (1999) Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81:774–782PubMedCrossRef Hofmann UB, Westphal JR, Waas ET et al (1999) Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81:774–782PubMedCrossRef
9.
go back to reference D’Alessio S, Margheri F, Pucci M et al (2004) Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. Int J Cancer 110:125–133PubMedCrossRef D’Alessio S, Margheri F, Pucci M et al (2004) Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. Int J Cancer 110:125–133PubMedCrossRef
10.
go back to reference Itoh T, Tanioka M, Matsuda H et al (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177–181PubMedCrossRef Itoh T, Tanioka M, Matsuda H et al (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177–181PubMedCrossRef
11.
go back to reference Bjorklund M, Heikkila P, Koivunen E (2004) Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem 279:29589–29597PubMedCrossRef Bjorklund M, Heikkila P, Koivunen E (2004) Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem 279:29589–29597PubMedCrossRef
12.
13.
14.
go back to reference Fidler IF, Schroit AJ (1998) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta 948:151–173 Fidler IF, Schroit AJ (1998) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta 948:151–173
15.
go back to reference Cecconi O, Calorini L, Mannini A et al (1997) Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages. Clin Exp Metastasis 15:94–101PubMedCrossRef Cecconi O, Calorini L, Mannini A et al (1997) Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages. Clin Exp Metastasis 15:94–101PubMedCrossRef
16.
go back to reference Calorini L, Mannini A, Bianchini F et al (1999) Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. Clin Exp Metastasis 17:889–895PubMedCrossRef Calorini L, Mannini A, Bianchini F et al (1999) Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. Clin Exp Metastasis 17:889–895PubMedCrossRef
17.
go back to reference Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78PubMedCrossRef Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78PubMedCrossRef
18.
go back to reference Sica A, Schioppa T, Mantovani A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727PubMedCrossRef Sica A, Schioppa T, Mantovani A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727PubMedCrossRef
19.
go back to reference Lin EY, Nguyena AV, Russellb RG et al (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727–740PubMedCrossRef Lin EY, Nguyena AV, Russellb RG et al (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727–740PubMedCrossRef
20.
go back to reference Fallani A, Calorini L, Mannini A et al (2006) Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line. Prostaglandins Other Lipid Mediat 81:171–177PubMedCrossRef Fallani A, Calorini L, Mannini A et al (2006) Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line. Prostaglandins Other Lipid Mediat 81:171–177PubMedCrossRef
21.
go back to reference Gattoni-Celli S, Calorini L, Simile MM et al (1993) Modulation by MHC class I antigens of the biology of melanoma cells. Non immunological mechanism. Melanoma Res 3:285–289PubMed Gattoni-Celli S, Calorini L, Simile MM et al (1993) Modulation by MHC class I antigens of the biology of melanoma cells. Non immunological mechanism. Melanoma Res 3:285–289PubMed
22.
go back to reference Chen TR (1997) In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104:255–262CrossRef Chen TR (1997) In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104:255–262CrossRef
23.
go back to reference Bianchini F, D’Alessio S, Fibbi G et al (2006) Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. Oncol Rep 15:709–714PubMed Bianchini F, D’Alessio S, Fibbi G et al (2006) Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. Oncol Rep 15:709–714PubMed
24.
go back to reference Thompson JE, Cubbon RM, Cummings RT et al (2002) Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 12:1219–1223PubMedCrossRef Thompson JE, Cubbon RM, Cummings RT et al (2002) Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 12:1219–1223PubMedCrossRef
25.
go back to reference Jaleel M, Shenoy AR, Visweswariah SS (2004) Tyrphostins are inhibitors of guanylyl and adenylyl cyclases. Biochemistry 43:8247–8255PubMedCrossRef Jaleel M, Shenoy AR, Visweswariah SS (2004) Tyrphostins are inhibitors of guanylyl and adenylyl cyclases. Biochemistry 43:8247–8255PubMedCrossRef
27.
go back to reference Kim J, Yu W, Kovalski K et al (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353–362PubMedCrossRef Kim J, Yu W, Kovalski K et al (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353–362PubMedCrossRef
28.
go back to reference Lakka SS, Gondi CS, Dinh DH et al (2005) Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem 280:21882–21892PubMedCrossRef Lakka SS, Gondi CS, Dinh DH et al (2005) Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem 280:21882–21892PubMedCrossRef
29.
go back to reference Harvey SR, Hurd TC, Markus G et al (2003) Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res 9:4935–4943PubMed Harvey SR, Hurd TC, Markus G et al (2003) Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res 9:4935–4943PubMed
30.
go back to reference Saito K, Takeha S, Shiba K et al (2000) Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis. Int J Cancer 86:24–29PubMedCrossRef Saito K, Takeha S, Shiba K et al (2000) Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis. Int J Cancer 86:24–29PubMedCrossRef
31.
go back to reference Denkert C, Kobel M, Berger S et al (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303–308PubMed Denkert C, Kobel M, Berger S et al (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303–308PubMed
32.
go back to reference Itoh T, Tanioka M, Matsuda H et al (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177–181PubMedCrossRef Itoh T, Tanioka M, Matsuda H et al (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177–181PubMedCrossRef
33.
go back to reference Huang S, Van Arsdall M, Tedjarati S et al (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134–1142PubMed Huang S, Van Arsdall M, Tedjarati S et al (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134–1142PubMed
34.
go back to reference Hiratsuka S, Nakamura K, Iwai S et al (2002) MMP-9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289–300PubMedCrossRef Hiratsuka S, Nakamura K, Iwai S et al (2002) MMP-9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289–300PubMedCrossRef
Metadata
Title
Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells
Authors
Chiara Marconi
Francesca Bianchini
Antonella Mannini
Gabriele Mugnai
Salvatore Ruggieri
Lido Calorini
Publication date
01-05-2008
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 3/2008
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-007-9136-0

Other articles of this Issue 3/2008

Clinical & Experimental Metastasis 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine